The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized Trial
In conclusion, the genetic variants investigated were not crucial for the clinical response to metformin in PCOS.
Source: Basic and Clinical Pharmacology and Toxicology - Category: Drugs & Pharmacology Authors: Andreas J. T. Pedersen, Tore Bjerregaard Stage, Dorte Glintborg, Marianne Andersen, Mette Marie Hougaard Christensen Tags: Original Article Source Type: research
More News: Drugs & Pharmacology | Eating Disorders & Weight Management | Fortamet | Genetics | Insulin | Metformin | Obesity | Ovaries | Polycystic Ovary Syndrome | Study | Toxicology | Women